top of page
S379_CD3F PDL1 MHCI 40x_1Snapshot1.tif
Main logo (RGB) BIANCO.png

Reprogramming the solid tumor microenvironment
to unlock
the full potential of cancer immunotherapy

S387_CD45RO FOXP3_1 series_z1.tif

This is Lever Bio

Our Vision

Our vision is to unlock biotech innovation in immuno-oncology working with researchers, universities and research centers to ultimately improve patient outcomes.

Icone collegamenti_Tavola disegno 1 copia 48.png
S379_CD3 CD4 CD8 40x_1Snapshot1.tif

Our Approach

We focus on reprogramming the solid tumor microenvironment to foster anti-cancer immune response enhancing the recruitment, activation and sustained function of cytotoxic T lymphocytes against solid tumors.

Icone collegamenti_Tavola disegno 1 copia 46.png
S375_PD1-PDL1-IFNg_3_40XSnapshot1.tif

Our compounds aim to be solid tumor microenvironment reprogramming agents and T-cell fitness potentiators

Icone collegamenti_Tavola disegno 1 copia 47.png
S379_CD3 CD4 CD8 40x_2Snapshot1 copia.tif
Icone collegamenti.png

Join Lever Bio in advancing promising research and driving innovative drug development in the immuno-oncology field

News & Updates

bottom of page